See original here: CorMedix Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities
See original here: CorMedix Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities
Original post: Replimune Announces Biologics License Application Acceptance and Priority Review for RP1 for the Treatment of Advanced Melanoma
Read the original post: Pacira BioSciences Strengthens Executive Leadership Team with Two Key Appointments
Visit link: ORYZON announces appointment of Dr. Pierre Beaurang as Strategy and Business Development Advisor
View original post here: ARS Pharmaceuticals Launches neffyinSchools Program Providing Free Life-Saving Needle-Free Epinephrine For Emergency Use to Eligible K-12 Schools
Read the rest here: Avid Recommends Stockholders Follow Recommendations of ISS and Glass Lewis and vote FOR the Transaction with GHO and Ampersand
Originally posted here: Keros Therapeutics Announces Effectiveness of Global License Agreement with Takeda to Advance Elritercept
See more here: Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population
Read the original: Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan
Read the rest here: Oragenics, Inc. Provides Shareholder Update on Strategic Progress and Announces Janet Huffman as Interim CEO
Recent Comments